Description

4H-Pyrano[3,4-D]Oxazol-2(3H)-One,Tetrahydro-7-Hydroxy-6-Methoxy-4,7A- is a high-purity, complex heterocyclic compound serving as a critical advanced pharmaceutical intermediate and key building block in organic synthesis. Its unique fused pyran-oxazole structure makes it invaluable for constructing novel molecular frameworks with potential biological activity. This compound is primarily sought by pharmaceutical R&D teams and fine chemical manufacturers engaged in developing new active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring sophisticated heterocyclic chemistry.

Application

• Pharmaceutical Intermediate: Key synthetic precursor in the research and development of novel drug candidates, especially those targeting the central nervous system or possessing anti-inflammatory properties.
• Organic Synthesis Building Block: Used in complex multi-step syntheses to construct fused heterocyclic systems prevalent in modern medicinal chemistry.
• Research Chemical: Serves as a standard or starting material in academic and industrial research laboratories for studying structure-activity relationships (SAR) and new synthetic methodologies.
• Agrochemical Development: Potential intermediate in the synthesis of new-generation herbicides or fungicides that utilize complex oxygen and nitrogen-containing heterocycles.
• Material Science Research: Investigated as a monomer or precursor for specialty polymers and advanced organic materials with specific optical or electronic properties.

Basic Information

Item	Detail
Product Name	4H-Pyrano[3,4-D]Oxazol-2(3H)-One,Tetrahydro-7-Hydroxy-6-Methoxy-4,7A-
CAS No.	211804-30-7
Molecular Formula	C8H11NO5
Molecular Weight	201.18 g/mol
Synonyms	7-Hydroxy-6-methoxy-2,3,4,7a-tetrahydro-4H-pyrano[3,4-d][1,3]oxazol-2-one; Tetrahydro-7-hydroxy-6-methoxy-4H-pyrano[3,4-d]oxazol-2(3H)-one; 4H-Pyrano[3,4-d]oxazol-2(3H)-one, tetrahydro-7-hydroxy-6-methoxy-; 211804-30-7; 7-Hydroxy-6-methoxy-2,3,4,7a-tetrahydro-4H,5H-pyrano[3,4-d]oxazol-2-one; Fused pyran-oxazolone derivative
EINECS	Contact for details

Quality Control

Our production of 4H-Pyrano[3,4-D]Oxazol-2(3H)-One,Tetrahydro-7-Hydroxy-6-Methoxy-4,7A- adheres to stringent quality management systems. Every batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via NMR and IR spectroscopy, to ensure it meets the exacting standards required for pharmaceutical R&D. A detailed Certificate of Analysis (COA) is provided with each shipment, documenting all critical quality attributes.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at controlled room temperature (15-25°C). This compound is light-sensitive (store away from light) and may be hygroscopic (moisture-sensitive); therefore, containers should be kept sealed under an inert atmosphere when not in use to prevent degradation and moisture uptake.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (NMR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.